Your browser doesn't support javascript.
loading
Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.
Madonna, Rosalinda; Van Laake, Linda W; Davidson, Sean M; Engel, Felix B; Hausenloy, Derek J; Lecour, Sandrine; Leor, Jonathan; Perrino, Cinzia; Schulz, Rainer; Ytrehus, Kirsti; Landmesser, Ulf; Mummery, Christine L; Janssens, Stefan; Willerson, James; Eschenhagen, Thomas; Ferdinandy, Péter; Sluijter, Joost P G.
Afiliación
  • Madonna R; Institute of Cardiology and Center of Excellence on Aging, 'G. d'Annunzio' University - Chieti, Chieti, Italy Texas Heart Institute, Houston, USA.
  • Van Laake LW; Hubrecht Institute, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Davidson SM; The Hatter Cardiovascular Institute, Institute of Cardiovascular Science, University College London, London, UK.
  • Engel FB; Experimental Renal and Cardiovascular Research, Department of Nephropathology, Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Hausenloy DJ; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore, National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore, Singapore The National Institute of Health Research University College London Hospitals Biomedical Research Centre, London,
  • Lecour S; MRC Cape Heart Unit, Hatter Cardiovascular Research Institute, University of Cape Town, Cape Town, South Africa.
  • Leor J; Neufeld Cardiac Research Institute, Tel-Aviv University, Tel Aviv-Yafo, Israel Tamman Cardiovascular Research Institute, Sheba Medical Center, Tel HaShomer, Israel Sheba Center for Regenerative Medicine, Stem Cell, and Tissue Engineering, Tel Hashomer, Israel.
  • Perrino C; Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy.
  • Schulz R; Institute of Physiology, Justus-Liebig Giessen University of Giessen, Gießen, Germany.
  • Ytrehus K; Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
  • Landmesser U; Department of Cardiology, Charite Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
  • Mummery CL; Leiden University Medical Center, Leiden, The Netherlands.
  • Janssens S; Department of Cardiovascular Sciences, Clinical Cardiology, KU Leuven, Leuven, Belgium.
  • Willerson J; Department of Cardiology, Texas Heart Institute, Houston, TX, USA.
  • Eschenhagen T; Department of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, Hamburg 20246, Germany.
  • Ferdinandy P; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary Pharmahungary Group, Szeged, Hungary j.sluijter@umcutrecht.nl peter.ferdinandy@pharmahungary.com.
  • Sluijter JP; University Medical Center Utrecht, Utrecht, The Netherlands j.sluijter@umcutrecht.nl peter.ferdinandy@pharmahungary.com.
Eur Heart J ; 37(23): 1789-98, 2016 06 14.
Article en En | MEDLINE | ID: mdl-27055812

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Isquemia Miocárdica / Tratamiento Basado en Trasplante de Células y Tejidos / Corazón / Insuficiencia Cardíaca Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Eur Heart J Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Isquemia Miocárdica / Tratamiento Basado en Trasplante de Células y Tejidos / Corazón / Insuficiencia Cardíaca Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Eur Heart J Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos